Accurate Medical Systems, Inc. is an intellectual property (IP) company established to acquire, create, develop, refine and commercialize innovations in blood glucose measurement/monitoring and other attractive markets. The Company’s fundamental focus is on products and technologies that will improve patient outcomes and lower healthcare costs. The Company has a portfolio of highly advanced, proven and protected technologies. The Company’s intellectual property (IP) portfolio includes designs for: - Novel Oral Anticoagulant - Therapeutic composition for safer, lower cost, and more effective anticoagulant, antithrombotic, fibrinolytic, and vascular health medicaments - Non-Fouling Peripheral IV Catheter - Biocompatible coating chemistries for IV’s, catheters and other implantables - Non-Invasive Consumer Blood Glucose Monitor - Accurate, convenient, and needle-free blood sugar measurement IP - Automated Clinical Continuous Glucose Monitoring System - Accurate automated in-patient blood sugar monitoring IP - Enhanced Biosensor Technology - More effective, reliable and accurate blood sugar measurement - Diabetic-Friendly Test Strip Dispenser - Added convenience to improve blood sugar testing compliance. Our primary business model is licensing our IP to others for manufacturing and distribution of products incorporating our technologies, compositions, designs and significant technological “know how”. For more information, contact our offices. We look forward to speaking with you in greater depth regarding opportunities for commercialization relationships.